These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 10198217)

  • 1. Hairpin ribozyme specificity in vivo: a case of promiscuous cleavage.
    Denman RB
    Biochem Biophys Res Commun; 1999 Apr; 257(2):356-60. PubMed ID: 10198217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Self-cleaving-ribozyme-mediated reduction of betaAPP in human rhabdomyosarcoma cells.
    Dolzhanskaya N; Conti J; Schwenk V; Merz G; Denman RB
    Arch Biochem Biophys; 2001 Mar; 387(2):223-32. PubMed ID: 11370845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel cleavage of a hammerhead ribozyme targeted to beta-amyloid peptide precursor mRNA.
    Denman R; Miller DL
    Arch Biochem Biophys; 1993 Sep; 305(2):392-400. PubMed ID: 8373177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Facilitated reduction of beta-amyloid peptide precursor by synthetic oligonucleotides in COS-7 cells expressing a hammerhead ribozyme.
    Denman RB; Smedman M; Abraham M; Chen-Hwang MC; Currie JR
    Arch Biochem Biophys; 1997 Dec; 348(1):82-90. PubMed ID: 9390177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of antisense and ribozyme accessible sites on native mRNAs: application to NCOA3 mRNA.
    Scherr M; LeBon J; Castanotto D; Cunliffe HE; Meltzer PS; Ganser A; Riggs AD; Rossi JJ
    Mol Ther; 2001 Nov; 4(5):454-60. PubMed ID: 11708882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo ribozyme targeting of betaAPP+ mRNAs.
    Dolzhanskaya N; Conti J; Merz G; Denman RB
    Mol Cell Biol Res Commun; 2000 Oct; 4(4):239-47. PubMed ID: 11409919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity and cleavage site specificity of an anti-HIV-1 hairpin ribozyme in human T cells.
    Yamada O; Kraus G; Leavitt MC; Yu M; Wong-Staal F
    Virology; 1994 Nov; 205(1):121-6. PubMed ID: 7975207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attenuation of telomerase activity by hammerhead ribozymes targeting human telomerase RNA and telomerase reverse transcriptase in pancreatic carcinoma cells.
    Hayashidani Y; Hiyama E; Murakami Y; Sueda T
    Hiroshima J Med Sci; 2005 Mar; 54(1):21-7. PubMed ID: 15847061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction and transfection of a ribozyme targeting human caspase-3.
    Cronin D; Daly C; O'Doherty T; Heenan M; Scanlon KJ; Clynes M
    Anticancer Res; 2004; 24(2A):425-31. PubMed ID: 15152940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A cis and trans adenine-dependent hairpin ribozyme against Tpl-2 target.
    Li YL; Torchet C; Vergne J; Maurel MC
    Biochimie; 2007 Oct; 89(10):1257-63. PubMed ID: 17703868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ribozyme targeted on HPV16E6 mRNA induced apoptosis on human cervical carcinoma CaSKi cells.
    Zheng YF; Zhang JR
    Ai Zheng; 2003 May; 22(5):458-62. PubMed ID: 12753702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ribozyme knockdown of the gamma-subunit of rod cGMP phosphodiesterase alters the ERG and retinal morphology in wild-type mice.
    Liu J; Timmers AM; Lewin AS; Hauswirth WW
    Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3836-44. PubMed ID: 16186371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and expression of chimeric U1/ribozyme transgenes.
    Abounader R; Montgomery R; Dietz H; Laterra J
    Methods Mol Biol; 2004; 252():209-19. PubMed ID: 15017051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ribozyme mediated degradation of beta-amyloid peptide precursor mRNA in COS-7 cells.
    Denman RB; Smedman M; Ju W; Rubenstein R; Potempska A; Miller DL
    Nucleic Acids Res; 1994 Jun; 22(12):2375-82. PubMed ID: 8036167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oligonucleotide scanning of native mRNAs in extracts predicts intracellular ribozyme efficiency: ribozyme-mediated reduction of the murine DNA methyltransferase.
    Scherr M; Reed M; Huang CF; Riggs AD; Rossi JJ
    Mol Ther; 2000 Jul; 2(1):26-38. PubMed ID: 10899825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engineered RNase P ribozymes inhibit gene expression and growth of cytomegalovirus by increasing rate of cleavage and substrate binding.
    Trang P; Hsu A; Zhou T; Lee J; Kilani AF; Nepomuceno E; Liu F
    J Mol Biol; 2002 Jan; 315(4):573-86. PubMed ID: 11812131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new type of hairpin ribozyme consisting of three domains.
    Komatsu Y; Kanzaki I; Shirai M; Ohtsuka E
    Biochemistry; 1997 Aug; 36(32):9935-40. PubMed ID: 9245427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro cleavage of an N-ras messenger-like RNA by a ribozyme.
    Stephenson P; Gibson I
    Antisense Res Dev; 1991; 1(3):261-8. PubMed ID: 1668256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Ribozyme targeted the point-mutation of activated oncogene inhibits its expression in vivo].
    Liu G; Chen Y; Zhao X; Dong Y; Chen D
    Yi Chuan Xue Bao; 1996; 23(6):477-85. PubMed ID: 9084224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and in vitro activity of ribozymes against mRNA of a rat membrane inhibitor of complement.
    Inui O; Tanaka T; Dohi N; Okada N; Okada H; Kikuchi Y
    Nucleic Acids Symp Ser; 1997; (37):223-4. PubMed ID: 9586080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.